Literature DB >> 20705244

Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells.

Adam S Lazorchak1, Dou Liu, Valeria Facchinetti, Annarita Di Lorenzo, William C Sessa, David G Schatz, Bing Su.   

Abstract

Mammalian target of rapamycin (mTOR) is an important mediator of phosphoinositol-3-kinase (PI3K) signaling. PI3K signaling regulates B cell development, homeostasis, and immune responses. However, the function and molecular mechanism of mTOR-mediated PI3K signaling in B cells has not been fully elucidated. Here we show that Sin1, an essential component of mTOR complex 2 (mTORC2), regulates B cell development. Sin1 deficiency results in increased IL-7 receptor (il7r) and RAG recombinase (rag1 and rag2) gene expression, leading to enhanced pro-B cell survival and augmented V(D)J recombinase activity. We further show that Akt2 specifically mediates the Sin1-mTORC2 dependent suppression of il7r and rag gene expression in B cells by regulating FoxO1 phosphorylation. Finally, we demonstrate that the mTOR inhibitor rapamycin induces rag expression and promotes V(D)J recombination in B cells. Our study reveals that the Sin1/mTORC2-Akt2 signaling axis is a key regulator of FoxO1 transcriptional activity in B cells. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705244      PMCID: PMC2957800          DOI: 10.1016/j.molcel.2010.07.031

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

Review 1.  Kinase phosphorylation: Keeping it all in the family.

Authors:  R T Peterson; S L Schreiber
Journal:  Curr Biol       Date:  1999-07-15       Impact factor: 10.834

Review 2.  Recent advances in the protein kinase B signaling pathway.

Authors:  James R Woodgett
Journal:  Curr Opin Cell Biol       Date:  2005-04       Impact factor: 8.382

Review 3.  Pre-BCR signals and the control of Ig gene rearrangements.

Authors:  Jamie K Geier; Mark S Schlissel
Journal:  Semin Immunol       Date:  2006-01-18       Impact factor: 11.130

Review 4.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

5.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

6.  A functional B cell receptor transgene allows efficient IL-7-independent maturation of B cell precursors.

Authors:  D Melamed; J A Kench; K Grabstein; A Rolink; D Nemazee
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

7.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.

Authors:  L Stephens; K Anderson; D Stokoe; H Erdjument-Bromage; G F Painter; A B Holmes; P R Gaffney; C B Reese; F McCormick; P Tempst; J Coadwell; P T Hawkins
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

8.  A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle.

Authors:  Z Li; D I Dordai; J Lee; S Desiderio
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

9.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

10.  Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase.

Authors:  H Suzuki; Y Terauchi; M Fujiwara; S Aizawa; Y Yazaki; T Kadowaki; S Koyasu
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

View more
  42 in total

Review 1.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

2.  Akt-mediated phosphorylation of XLF impairs non-homologous end-joining DNA repair.

Authors:  Pengda Liu; Wenjian Gan; Chunguang Guo; Anyong Xie; Daming Gao; Jianping Guo; Jinfang Zhang; Nicholas Willis; Arthur Su; John M Asara; Ralph Scully; Wenyi Wei
Journal:  Mol Cell       Date:  2015-02-05       Impact factor: 17.970

Review 3.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

Review 4.  mTOR complex 2 signaling and functions.

Authors:  Won Jun Oh; Estela Jacinto
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

Review 5.  The PI3K pathway in B cell metabolism.

Authors:  Julia Jellusova; Robert C Rickert
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-08-05       Impact factor: 8.250

Review 6.  Mammalian TOR signaling to the AGC kinases.

Authors:  Bing Su; Estela Jacinto
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-10-10       Impact factor: 8.250

Review 7.  Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.

Authors:  Daniel Fantus; Natasha M Rogers; Florian Grahammer; Tobias B Huber; Angus W Thomson
Journal:  Nat Rev Nephrol       Date:  2016-08-01       Impact factor: 28.314

8.  Integrated signaling in developing lymphocytes: the role of DNA damage responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 9.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

Review 10.  mTOR, metabolism, and the regulation of T-cell differentiation and function.

Authors:  Adam T Waickman; Jonathan D Powell
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.